Skip to main content
Premium Trial:

Request an Annual Quote

Co-Diagnostics HBDC, Mentors International Aim to Provide Low-Cost PCR Testing

NEW YORK (GenomeWeb News) – Co-Diagnostics HBDC and Mentors International have inked an agreement to offer real-time PCR-based tests in developing nations at lower costs, they announced today.

Starting with a pilot program in Guatemala and an initial testing focus on tuberculosis, Co-Diagnostics HBDC will provide low-cost testing reagents, and Mentors will leverage its international network to create low-cost testing facilities. Mentors will identify machines that cost less and provide training to second-generation workers in its microfinancing program.

Mentors is a non-profit microfinancing organization that aims to help the impoverished in developing countries achieve self-sufficiency. It creates partner foundations in developing countries and provides start-up support, training, operational funding, and loan capital for those partner foundations.

"Mentors International is helping to provide a framework to ensure that low test prices make it all the way through to the patient," Co-Diagnostics HBDC CEO Brent Satterfield said in a statement. "In Guatemala, this could reduce the price of tuberculosis real-time PCR testing for the patient to less than 10 percent of what they currently pay. This should dramatically increase the number of patients who have access to high-quality diagnostic care."

Co-Diagnostics HBDC, established last month, is a joint venture between Co-Diagnostics and DNA Logix to tackle infectious diseases in high-burden developing countries.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.